Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 3
2020 1
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
CIDP associated with Sjögren's syndrome.
Seeliger T, Gingele S, Bönig L, Konen FF, Körner S, Prenzler N, Thiele T, Ernst D, Witte T, Stangel M, Skripuletz T. Seeliger T, et al. Among authors: konen ff. J Neurol. 2021 Aug;268(8):2908-2912. doi: 10.1007/s00415-021-10459-z. Epub 2021 Feb 21. J Neurol. 2021. PMID: 33611611
Switch from intravenous to subcutaneous immunoglobulin IgPro20 in CIDP patients: a prospective observational study under real-world conditions.
Gingele S, Koch M, Saparilla AC, Körner GM, von Hörsten J, Gingele M, Seeliger T, Konen FF, Hümmert MW, Neyazi A, Stangel M, Skripuletz T. Gingele S, et al. Among authors: konen ff. Ther Adv Neurol Disord. 2021 Apr 16;14:17562864211009100. doi: 10.1177/17562864211009100. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 33948119 Free PMC article.
Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients.
Gingele S, Jacobus TL, Konen FF, Hümmert MW, Sühs KW, Schwenkenbecher P, Ahlbrecht J, Möhn N, Müschen LH, Bönig L, Alvermann S, Schmidt RE, Stangel M, Jacobs R, Skripuletz T. Gingele S, et al. Among authors: konen ff. Cells. 2018 Dec 28;8(1):12. doi: 10.3390/cells8010012. Cells. 2018. PMID: 30597851 Free PMC article.